India’s Supreme Court set to rule whether Monsanto maintains its patent rights on GMO Bt Corn

e c e b b b
Credit: Amit Dave/Reuters

All eyes in India are currently on the country’s Supreme Court where the agro-biotech giant Monsanto is battling to reclaim its patent for the pioneering Bt Cotton technology. This will be the court’s first interpretation of convoluted issues relating to the patentability of plant varieties and its decision will be a turning point for the entire biotechnology industry and its ability to protect plant-related inventions in India.

With hundreds of patent applications in the area already granted, and others pending, it is to be hoped that the court examines all the issues exhaustively so that the ruling does not prove to be a nemesis for these patent applications and future biotech innovations.

The case began with an infringement suit filed in Delhi by Monsanto against the Indian agribusiness company, Nuziveedu Seeds earlier this year. A two-judge bench of the Delhi High Court (DHC) revoked the company’s Indian patent covering the DNA expression construct and a method for preparing the transgenic Bt Cotton plant using this expression construct.

Read full, original article: Supreme Court of India set to rule in crucial plant innovation dispute

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
ChatGPT-Image-Sep-2-2026-10_30_14-PM
Zero: That is the official American measles death toll for 2026. Here is what RFK Jr.’s CDC leaves out.
ChatGPT-Image-Sep-13-2026-10_24_17-AM
Bayer urges court to approve $7.25 billion Monsanto Roundup settlement that could limit its future liabilities
ChatGPT-Image-Sep-14-2026-11_36_25-AM
How the reckless AI race among Anthropic, OpenAI and China spawned today’s safety crisis
Screenshot-2026-09-14-at-10.52.30-AM
AI is being used in dangerous bioscience experiments
ChatGPT-Image-Sep-15-2026-06_05_13-PM
CRISPR fine-tuning unlocks vitamin C-rich potatoes without yield loss
screenshot at  am
‘Glyphosate is not carcinogenic’: Independent EU chemical oversight agency reaffirms—for the 3rd time in 9 years—that the herbicide is safe-as-used
Screenshot-2026-09-14-at-3.07.56-PM
Trump EPA rolls back power-plant climate rules—and moves to block future carbon limits
Screenshot-2026-08-04-at-11.36.16-AM
Viewpoint: Emotion-driven stories of doctors allegedly ignoring patient concerns are driving vaccine hesitancy
ChatGPT-Image-Sep-14-2026-02_57_24-PM
Viewpoint: 6 Atlantic Council expert opinions on the U.S., China and the AI safety crisis
ChatGPT-Image-Sep-15-2026-05_59_18-PM
RFK Jr. spent two years distancing himself from Children’s Health Defense. Now he’s keynoting its anti-vaccine DC conference.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.